.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Healthtrust
QuintilesIMS
Chinese Patent Office
Deloitte
Johnson and Johnson
Argus Health
AstraZeneca
Federal Trade Commission
Julphar

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,132,712

« Back to Dashboard

Which drugs does patent 8,132,712 protect, and when does it expire?


Patent 8,132,712 protects QVAR REDIHALER and PROAIR HFA and is included in two NDAs.

This patent has eighteen patent family members in seventeen countries.

Summary for Patent: 8,132,712

Title:Metered-dose inhaler
Abstract: A metered dose inhaler dose counter, the counter includes: an actuator; a rotary gear wheel having a plurality of ratchet teeth; a driver for driving the rotary gear in a step-wise fashion in response to displacement of the actuator; a pawl that prevents reverse rotation of the rotary gear; and a display coupled to the rotary gear.
Inventor(s): Fenlon; Derek (Waterford, IE)
Assignee: Ivax Pharmaceuticals Ireland (Waterford, IE)
Application Number:12/532,762
Patent Claim Types:
see list of patent claims
Use; Delivery;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-001Aug 3, 2017RXYesNo► Subscribe► SubscribeY
Norton Waterford
QVAR REDIHALER
beclomethasone dipropionate
AEROSOL, METERED;INHALATION207921-002Aug 3, 2017RXYesYes► Subscribe► SubscribeY
Teva Branded Pharm
PROAIR HFA
albuterol sulfate
AEROSOL, METERED;INHALATION021457-001Oct 29, 2004BXRXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,132,712

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom076999.0Apr 11, 2007
PCT Information
PCT FiledApril 01, 2008PCT Application Number:PCT/EP2008/002590
PCT Publication Date:October 09, 2008PCT Publication Number: WO2008/119552

International Patent Family for Patent: 8,132,712

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Eurasian Patent Organization016831► Subscribe
China101657829► Subscribe
Spain2404818► Subscribe
European Patent Office2135199► Subscribe
Eurasian Patent Organization200970907► Subscribe
Denmark2135199► Subscribe
Hong Kong1141349► Subscribe
United Kingdom0706999► Subscribe
Canada2682528► Subscribe
Israel201256► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Julphar
AstraZeneca
Moodys
QuintilesIMS
Argus Health
Healthtrust
Federal Trade Commission
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot